- Home
- NCLH vs PEN Comparison
NCLH vs PEN Comparison
Compare NCLH & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCLH
- PEN
- Stock Information
- Founded
- NCLH 1966
- PEN 2004
- Country
- NCLH United States
- PEN United States
- Employees
- NCLH N/A
- PEN N/A
- Industry
- NCLH Marine Transportation
- PEN Medical/Dental Instruments
- Sector
- NCLH Consumer Discretionary
- PEN Health Care
- Exchange
- NCLH Nasdaq
- PEN Nasdaq
- Market Cap
- NCLH 10.7B
- PEN 9.7B
- IPO Year
- NCLH 2013
- PEN 2015
- Fundamental
- Price
- NCLH $17.50
- PEN $279.49
- Analyst Decision
- NCLH Buy
- PEN Strong Buy
- Analyst Count
- NCLH 17
- PEN 16
- Target Price
- NCLH $29.12
- PEN $307.19
- AVG Volume (30 Days)
- NCLH 21.0M
- PEN 482.1K
- Earning Date
- NCLH 11-04-2025
- PEN 11-05-2025
- Dividend Yield
- NCLH N/A
- PEN N/A
- EPS Growth
- NCLH 11.76
- PEN 367.34
- EPS
- NCLH 1.40
- PEN 4.14
- Revenue
- NCLH $9,692,558,000.00
- PEN $1,333,798,000.00
- Revenue This Year
- NCLH $8.20
- PEN $15.52
- Revenue Next Year
- NCLH $10.58
- PEN $14.20
- P/E Ratio
- NCLH $12.55
- PEN $67.74
- Revenue Growth
- NCLH 3.59
- PEN 14.61
- 52 Week Low
- NCLH $14.21
- PEN $221.26
- 52 Week High
- NCLH $29.29
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- NCLH 22.27
- PEN 65.63
- Support Level
- NCLH $18.75
- PEN $274.20
- Resistance Level
- NCLH $19.47
- PEN $283.84
- Average True Range (ATR)
- NCLH 0.78
- PEN 8.42
- MACD
- NCLH -0.21
- PEN 4.75
- Stochastic Oscillator
- NCLH 1.70
- PEN 91.17
About NCLH Norwegian Cruise Line Holdings Ltd.
Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 71,000). It operates 34 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 38,400 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.